EMA Application withdrawn: Opsiria (sirolimus) — Santen Oy

View source ↗

Summary

The EMA withdrew the application for Opsiria (sirolimus) by Santen Oy for uveitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveitis

Drugs mentioned

• Opsiria (sirolimus)

Snippet

Status: Application withdrawn. Therapeutic area: Uveitis. MAH: Santen Oy. Decision date: 27/05/2016